Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
$4.18−0.23 (-5.22%)
Close on Nov 17, 2026Market cap $103.61MP/E –Yield –
Lexaria Bioscience price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Lexaria Bioscience's price to sales ratio was 445.9× on Oct 30, 2026, against 415.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 30, 2026 | 445.9× | +189.5 |
| 2025 | Dec 31, 2025 | 256.4× | −139.4 |
| 2023 | Sep 29, 2023 | 395.8× | −83.2 |
| 2021 | Dec 31, 2021 | 479.0× | – |
See a number that looks wrong?